Loading stock data…
Veeva Systems Inc. (VEEV)
$275.09-9.29 (-3.27%)
Pre-Market$271.00-4.09 (-1.49%)· Last close Sep 4
Veeva Systems Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Veeva Systems Inc. in the Healthcare sector is trading at $275.09 with a market capitalization of $25.9B. Wall Street consensus targets $295.18 (28 analysts), implying a +7.3% move over the next 12 months. The stock is currently 11% below its 52-week high of $310.50, remaining 38.5% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +7.3% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $882.95M↑ | $835.95M↑ | $811.24M↑ | $789.08M↑ | $759.04M |
| Gross Profit | $662.02M↑ | $622.47M↑ | $611.77M↑ | $593.83M↑ | $585.22M |
| Operating Income | $273.11M↑ | $245.88M↑ | $240.85M↑ | $195.91M↓ | $233.73M |
| Net Income | $260.94M↑ | $244.20M↑ | $236.20M↑ | $200.31M↓ | $228.19M |
Peer Comparison
JNJUNHPFE
Fundamentals
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pha...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$25.92B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
28.24
Beta
Defensive asset. Lower volatility than the S&P 500.
0.95
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.89%
Volume
Today's trading volume
1.15M
Recent News
Michael Burry Remains Bullish on Veeva but Trimmed His Position. What This Means for VEEV Stock.
Michael Burry remains bullish on Veeva but trimmed his stake after shares jumped more than 15% on a fiscal second-quarter earnings beat and a raised 2027 outlook.
Why Is Veeva Systems (VEEV) Winning Big In AI For Biopharma?
Veeva Systems (NYSE: VEEV) announced that Regeneron and Biogen have adopted its AI powered Vault CRM suite globally. The company also introduced Veeva Falcon Safety, a new agentic safety operations product for biopharma clients. Both moves expand Veeva Systems' AI focused offering across commercial and safety workflows in life sciences. These updates highlight how AI heavy software is becoming core infrastructure for healthcare and biopharma workflows. This connects directly to a wider set...
VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast
Veeva raises its fiscal 2027 outlook as Vault CRM adoption, R&D growth and Falcon AI momentum support expanding revenue and profitability.
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
VEEV's strong Q2 results, Vault CRM migrations and AI expansion support growth, while market saturation remains a key concern.
Michael Burry Warns Red-Hot AI Stock Is Overvalued
One software rally still looks attractive, another far less so